Janux Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$23.39(as of Sep 4, 1:38 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Janux Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$23.39
Ticker SymbolJANX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees103
CountyUSA
Market Cap$1,373.7M
EBIDTA-142.8M
10-Day Moving Average23.48
P/E Ratio-13.50
20-Day Moving Average23.83
Forward P/E Ratio0.00
50-Day Moving Average24.49
Earnings per Share-1.81
200-Day Moving Average34.06
Profit Margin-Infinity%
RSI42.86
Shares Outstanding60.1M
ATR1.26
52-Week High71.71
Volume455,625
52-Week Low21.97
Most Recent Support Level22.41
Book Value990.5M
Most Recent Resistance Level24.00
P/B Ratio1.44
Upper Keltner26.67
P/S Ratio-176.67
Lower Keltner21.00
Debt-to-Equity Ratio26.67
Next Earnings Date11/11/2025
Cash Surplus31.1M
Next Ex-Dividend DateUnknown

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer. Its clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor that is in Phase 1 clinical trial for the treatment of various solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. Janux Therapeutics, Inc. has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. The company was incorporated in 2017 and is headquartered in San Diego, California.

Janux Therapeutics Inc In Our Stock Scanner

As of Sep 04, 2025
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.